Arquitos returned 82.1% net of fees and expenses in 2025, compared to 12.8% for the Russell 2000. Read more here.
Key opportunities in the Global Small Cell Lung Cancer Therapeutics Market include the growing demand for advanced ...
The market is driven by increased biopharmaceutical research and scaling of cell and gene therapies, with opportunities in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback